The review by Li et al. [62] discusses the antitumor properties of TLRs, RIG-I-like receptors (RLRs), and STING-mediated innate immune pathways, in addition to the promising innate immune targets for potential application in cancer immunotherapy. Here, STING1 is linked to cancer.